News Briefs Ambit Biosciences Signs $390 Million Deal with Astellas VCJ Staff - 21 December 2009 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
